James Q. Del Rosso DO FAOCD FAADa,b,c and Leon Kircik MDd,e,f,g
aTouro University Nevada, Henderson, NV, bJDR Dermatology Research Center, Las Vegas, NV, cPrivate Practice,Thomas Dermatology, Las Vegas, NV dIndiana University School of Medicine, Indianapolis, IN eMount Sinai Medical Center, New York, NY fPhysicians Skin Care, PLLC, Louisville, KY gDermResearch, PLLC, Louisville, KY
of a topical delivery system that is effective and safe. The pharmacokinetic profile of a given NO-releasing formulation must also avoid adverse cutaneous or systemic sequelae. Sever- al NO delivery platforms have been evaluated, many for topical application and with ongoing development programs, and each with potential advantages and disadvantages, which have been summarized in the literature; these include acidi ed nitrate, diazeniumdiolates (NONOates), nanoparticles, probiotic patch, S-nitrosothiols (RSNOs), and NO-metal complexes.2,3,5,11,14,15,17,19,20 Studies completed with some NO-based topical formulations, such as with nanoparticles or with a macromolecule that in- corporates N-diazeniumdiolate donor technology, provide both cogent basic science and clinical research support for the use of NO-based topical therapy for the treatment of acne.11,14,15,17,19,38How Might a Nitric-Oxide Releasing Formulation Therapeutically Modify the Pathophysiology of Acne? Understanding of the pathophysiology of acne has increased substantially over the past one to two decades due to major advancements in basic science technologies, such as immunohistochemistry, gene array analysis, and real-time polymerase chain reaction, with studies supporting the new- er information on relevant pathways thoroughly summarized in the literature.32-35 Although follicular hyperkeratinization and microcomedone formation are well known to occur during the preclinical development of an acne lesion, sub- clinical in ammation characterized by T-helper (CD4+) cell and macrophage in ltration, follicular production of IL-1, upregulation of vascular adhesion molecules, and a relative absence of neutrophils has also been documented.32-35 Increased expression of IL-1 has been noted in association with comedone formation and in early in ammatory lesions and appears to play roles in both the initiation and propagation of acne.34 These data collectively support the presence of pre- clinical in ammation prior to both visible in ammatory and comedonal acne lesion emergence. Importantly, persistent in ammation is also present after visible acne lesions prog- ress from being palpable to becoming macular, with scar formation dependent on the capacity for physiologic tissue restoration within the dermal matrix.32,34
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.